Molecular Imaging of Newly Diagnosed Prostate Cancer

被引：4

作者：

Williams, Scott ^{[1
,2
]}

机构：

[1] Peter MacCallum Canc Ctr, Div Radiat Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia

[2] Univ Melbourne, Div Radiat Oncol, Melbourne, Vic, Australia

来源：

CANCER JOURNAL | 2020年 / 26卷 / 01期

关键词：

Positron emission tomography; prostate cancer; prostate-specific membrane antigen; POSITRON-EMISSION-TOMOGRAPHY; MEMBRANE ANTIGEN-EXPRESSION; GA-68-PSMA PET/CT; C-11-CHOLINE PET/CT; METASTASES; CARCINOMA; ACID; VALIDATION; RECURRENCE; ACCURACY;

D O I：

10.1097/PPO.0000000000000427

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography (PET) is a valuable imaging in evaluating many malignancies. There are various molecular imaging tracers that are currently being utilized with prostate cancer (PC). Several PET agents imaging different molecular processes in PC have reached the clinic. While all of these agents have demonstrated an advantage over conventional imaging, there are considerable differences in the performance of each in staging newly diagnosed PC. In this article, we review the current updates available of different PET tracers, with a strong focus on the emerging role of prostate-specific membrane antigen PET in the management of newly diagnosed PC.

引用

页码：43 / 47

页数：5

共 50 条

[21] Molecular multimodal hybrid imaging in prostate and bladder cancer
Maurer, T.
Eiber, M.
Krause, B. J.
UROLOGE, 2014, 53 (04): : 469 - +
[22] New Targets for PET Molecular Imaging of Prostate Cancer
Mena, Esther
Lindenberg, Liza M.
Choyke, Peter L.
SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 326 - 336
[23] Preliminary Treatment Considerations Among Men With Newly Diagnosed Prostate Cancer
Zeliadt, Steven B.
Moinpour, Carol M.
Blough, David K.
Penson, David F.
Hall, Ingrid J.
Smith, Judith Lee
Ekwueme, Donatus U.
Thompson, Ian M.
Keane, Thomas E.
Ramsey, Scott D.
AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (05) : E121 - E130
[24] Psychological Resilience in Newly Diagnosed Prostate Cancer Survivors: A Longitudinal Study
Chien, Ching-Hui
Liu, Kuan-Lin
Chuang, Cheng-Keng
Wu, Chun-Te
Pang, See-Tong
Yu, Kai-Jie
Lin, Po-Hung
CANCER NURSING, 2025,
[25] The Influence of Distress on Knowledge Transfer for Men Newly Diagnosed with Prostate Cancer
Hovey, R. B.
Cuthbertson, K. E. S.
Birnie, K. A.
Robinson, J. W.
Thomas, B. C.
Massfeller, H. F.
Ruether, J. D.
Scott, C.
JOURNAL OF CANCER EDUCATION, 2012, 27 (03) : 540 - 545
[26] Newly Diagnosed Oligometastatic Prostate Cancer: Current Controversies and Future Developments
Fossati, Nicola
Giannarini, Gianluca
Joniau, Steven
Sedelaar, Michiel
Sooriakumaran, Prasanna
Spahn, Martin
Roupret, Morgan
EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 587 - 600
[27] Decisional Conflict in Economically Disadvantaged Men With Newly Diagnosed Prostate Cancer
Kaplan, Alan L.
Crespi, Catherine M.
Saucedo, Josemanuel D.
Connor, Sarah E.
Litwin, Mark S.
Saigal, Christopher S.
CANCER, 2014, 120 (17) : 2721 - 2727
[28] Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
Buelens, Sarah
De Bleser, Elise
Dhondt, Bert
Verla, Wesley
Decaestecker, Karel
Ost, Piet
Fonteyne, Valerie
De Man, Kathia
Standaert, Chloe
Rottey, Sylvie
Lumen, Nicolaas
WORLD JOURNAL OF UROLOGY, 2019, 37 (12) : 2565 - 2571
[29] Evaluating an educational intervention to alleviate distress amongst men with newly diagnosed prostate cancer and their partners
Hedden, Lindsay
Wassersug, Richard
Mahovlich, Sarah
Pollock, Phil
Sundar, Monita
Bell, Robert H.
Goldenberg, Larry
Higano, Celestia S.
BJU INTERNATIONAL, 2017, 120 (5B) : E21 - E29
[30] Imaging for Prostate Cancer Recurrence
Maurer, Tobias
Eiber, Matthias
Fanti, Stefano
Budaeus, Lars
Panebianco, Valeria
EUROPEAN UROLOGY FOCUS, 2016, 2 (02): : 139 - 150

← 1 2 3 4 5 →